Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data01:16

Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data

Statistical inference techniques, paramount in hypothesis testing, differentiate into two broad categories: parametric and nonparametric statistics.
Parametric statistics, as the name suggests, assumes that data follow a specific distribution, often a normal distribution. This assumption enables robust hypothesis testing and estimation. Parametric methods, like the Student's t-test or Goodness-of-fit test, are frequently employed in biostatistics due to their robustness. For instance, comparing...
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters00:54

Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters

The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's overall...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EVALUATING MULTIPLEX DIAGNOSTIC TEST USING PARTIALLY ORDERED BAYES CLASSIFIER.

The annals of applied statistics·2026
Same author

Evaluating movement breaks as a public health strategy to mitigate the harms of prolonged sitting: a large-scale pragmatic intervention.

British journal of sports medicine·2026
Same author

Digital personalized trials of a multicomponent behavioral change intervention for increasing habitual low-intensity physical activity in middle-aged and older healthcare workers: results of a feasibility study.

Pilot and feasibility studies·2026
Same author

GENERALIZATION ERROR BOUNDS OF DYNAMIC TREATMENT REGIMES IN PENALIZED REGRESSION-BASED LEARNING.

Annals of statistics·2026
Same author

A SEQUENTIAL SIGNIFICANCE TEST FOR TREATMENT BY COVARIATE INTERACTIONS.

Statistica Sinica·2026
Same authorSame journal

Comparing Adaptive Interventions under a General Sequential Multiple Assignment Randomized Trial Design via Multiple Comparisons with the Best.

Journal of statistical planning and inference·2026

Related Experiment Video

Updated: May 15, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Published on: September 4, 2017

On the efficiency of nonparametric variance estimation in sequential dose-finding.

Chih-Chi Hu1, Ying Kuen Cheung

  • 1Department of Biostatistics, Columbia University, 722 West 168th Street, New York, New York 10032, U.S.A.

Journal of Statistical Planning and Inference
|January 19, 2013
PubMed
Summary
This summary is machine-generated.

Parametric variance assumptions in dose-finding studies offer minimal efficiency gains over non-parametric methods. Non-parametric variance estimation in sequential clinical trials is often sufficient, retaining over 90% efficiency.

More Related Videos

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
12:22

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

Related Experiment Videos

Last Updated: May 15, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Published on: September 4, 2017

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
12:22

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Modeling

Background:

  • Dose-finding studies often rely on quantile estimation, where accurate variance function specification is crucial.
  • Sequential study designs are particularly sensitive to variance assumptions, limiting post-collection sensitivity analysis.

Purpose of the Study:

  • To investigate the efficiency gains from parametric variance assumptions in sequential least squares recursion.
  • To compare parametric variance estimation with non-parametric approaches in dose-finding contexts.

Main Methods:

  • Asymptotic comparison of parametric (homoscedasticity) and non-parametric variance estimation.
  • Simulation studies under diverse scenarios to evaluate efficiency.

Main Results:

  • Parametric assumptions on variance yield only modest efficiency gains over non-parametric methods.
  • Non-parametric variance estimation retains at least 88% efficiency, often exceeding 90%, even when homoscedasticity holds.

Conclusions:

  • Avoiding parametric variance assumptions in sequential dose-finding is often justified due to limited gains.
  • Non-parametric variance estimation provides a robust and efficient alternative in clinical study design.